MA51617A
(en )
2020-11-25
DRUG DELIVERY MECHANISM
MA50557A
(en )
2020-09-16
PISTONS FOR DRUG DELIVERY DEVICES
IL275704A
(en )
2020-08-31
Oral pharmaceutical formulation comprising cannabinoids and poloxamer
MA56006A
(en )
2022-05-04
SUBCUTANEOUS HER2 ANTIBODY FORMULATIONS
MA49949A
(en )
2020-07-01
NEEDLE INSERTION MECHANISM FOR DRUG DELIVERY DEVICE
MA50904A
(en )
2020-09-23
NEEDLE INSERTION MECHANISM FOR DRUG DELIVERY DEVICE
UY4595S
(en )
2018-04-30
PORTABLE DRUG ADMINISTRATION DEVICE
DK3886944T3
(en )
2024-03-11
Drug delivery device
GB201807942D0
(en )
2018-06-27
Pharmaceutical formulation
MA47824A
(en )
2020-01-15
POLYANIONIC ADMINISTRATION OF NUCLEIC ACIDS
DK3727555T3
(en )
2023-06-26
ORAL DELIVERY OF ACTIVE DRUG SUBSTANCES
MA50189A
(en )
2021-05-19
CYCLIC OLIGOMER AND ABIRATERONE PHARMACEUTICAL FORMULATIONS AND PROCESSES FOR FORMING AND ADMINISTERING THE SAME
BR112017028140A2
(en )
2018-08-28
pharmaceutical formulations
MA49393A
(en )
2020-04-22
POLY (PHOSPHOESTERS) INTENDED FOR THE ADMINISTRATION OF NUCLEIC ACIDS
DK3709978T3
(en )
2023-06-12
Pharmaceutical oral formulation comprising bacteria
MA54245A
(en )
2022-02-23
TRANSDERMAL TEMPERATURE-REGULATING DRUG DELIVERY SYSTEM
SG11202010124SA
(en )
2020-11-27
Stable pharmaceutical formulation
MA50047A
(en )
2020-07-08
ORAL ADMINISTRATION OF GLP-1 PEPTIDIC ANALOGUES
MA55015A
(en )
2021-12-29
PHARMACEUTICAL FORMULATIONS
DK3908349T3
(en )
2024-09-16
MEDICATION DELIVERY DEVICE
MA41866A
(en )
2018-02-06
SELF-ASSEMBLING MOLECULES FOR TARGETED DRUG DELIVERY
FI20165467A
(en )
2017-12-07
Procedure for administering a user's medication
MA56220A
(en )
2022-04-20
OCULAR FORMULATIONS FOR THE DELIVERY OF MEDICINES AND THE PROTECTION OF THE ANTERIOR SEGMENT OF THE EYE
DK3453390T3
(en )
2024-03-25
PHARMACEUTICAL COMPOSITION CONTAINING POLYMERIZED DRUG
MA54373A
(en )
2022-03-16
COLON DRUG DELIVERY FORMULATION